Video

Discussion On Older Homeless Mortality Rates, Future Research

Author(s):

Rebecca T. Brown, MD, MPH, describes contributing factors to older homeless adult mortality and future topics of interest in this field.

A recent study by University of California, San Francisco (UCSF) investigators demonstrated rising rates of elderly homelessness, as well as the 2 main factors associated with mortality rates among this population.

Multivariable analyses of 117 homeless adults aged ≥50, surveyed in an Oakland-based study known as the HOPE HOME study, found that heart disease and cancer were the 2 leading causes of mortality.

The study’s author Rebecca T. Brown, MD, MPH, of the Division of Geriatrics in the University of California, San Francisco Department of Medicine spoke on HCPLive about her colleagues and her research on the topic.

“So, I would say there’s multiple factors contributing,” Brown said. “One is that when you’re experiencing homelessness, homelessness is a major competing demand for self care.”

Brown expressed concern about the ability for older homeless adults to receive medical care at all, given the added difficulties associated with not having housing or access to transportation. Brown added that it is difficult for a homeless adult to be treated for a health concern “even if you know you have heart disease, which many people may not know that they do, if they are not seeing a physician regularly.”

In addition, Brown discussed the topics she would like to learn more about having done this research. She added that nursing home use among homeless populations in the over 50 age bracket was something she was interested in doing more research into, as it is not a well-researched topic with regard to homelessness.

“We haven’t dived into the data yet, but there’s a lot of younger folks who are in and out of nursing homes,” Brown said. “So I think it would be really interesting to understand the use of nursing homes more and how that can be prevented in this population.”

Related Videos
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
What to Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
Arshad Khanani, MD: First Results from Fellow Eye Dosing of RGX-314 in nAMD | Image Credit: Sierra Eye Associates
Jonathan Barratt, MD | Credit: IgA Nephropathy Foundation
How Artificial Intelligence is Being Used in Lung Imaging, with Rachel Eddy, PhD
© 2024 MJH Life Sciences

All rights reserved.